• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盆腔炎的经济成本。

The economic cost of pelvic inflammatory disease.

作者信息

Washington A E, Arno P S, Brooks M A

出版信息

JAMA. 1986 Apr 4;255(13):1735-8.

PMID:3951103
Abstract

Pelvic inflammatory disease (PID) is one of the most widespread and debilitating diseases affecting women today. To calculate the economic costs of PID and PID-associated ectopic pregnancy and infertility in the United States, we analyzed data from local hospitals and from several state and national sources. Direct and indirect costs were computed. We found that the total cost of PID and PID-associated ectopic pregnancy and infertility exceeded +2.6 billion in 1984. By 1990, the estimated cost of PID and its sequelae will total +3.50 billion per year, if the annual medical care inflation is 5% and the incidence of PID remains constant during this six-year period. These estimated costs of PID and its associated sequelae emphasize the urgent need for effective programs to prevent PID.

摘要

盆腔炎(PID)是当今影响女性的最普遍且使人虚弱的疾病之一。为了计算美国盆腔炎及与盆腔炎相关的异位妊娠和不孕症的经济成本,我们分析了来自当地医院以及几个州和国家层面来源的数据。计算了直接成本和间接成本。我们发现,1984年盆腔炎及与盆腔炎相关的异位妊娠和不孕症的总成本超过26亿美元。到1990年,如果年医疗保健通胀率为5%且在此六年期间盆腔炎发病率保持不变,那么盆腔炎及其后遗症的估计成本每年将总计达35亿美元。这些盆腔炎及其相关后遗症的估计成本凸显了实施有效项目预防盆腔炎的迫切需求。

相似文献

1
The economic cost of pelvic inflammatory disease.盆腔炎的经济成本。
JAMA. 1986 Apr 4;255(13):1735-8.
2
Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.盆腔炎的治疗费用及支付来源。1983年至2000年的趋势与预测。
JAMA. 1991 Nov 13;266(18):2565-9.
3
Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial.盆腔炎及其后遗症的直接医疗费用:呈下降趋势,但仍数额巨大。
Obstet Gynecol. 2000 Mar;95(3):397-402. doi: 10.1016/s0029-7844(99)00551-7.
4
Economic consequences of pelvic inflammatory disease in the United States.美国盆腔炎的经济后果。
Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):848-51. doi: 10.1016/0002-9378(80)91069-8.
5
A refined estimate of the average lifetime cost of pelvic inflammatory disease.盆腔炎平均终生成本的精确估计。
Sex Transm Dis. 2003 May;30(5):369-78. doi: 10.1097/00007435-200305000-00001.
6
Costs of pelvic inflammatory disease and associated sequelae in Canada.
Can Dis Wkly Rep. 1988 Nov 12;14(45):206-8.
7
If pelvic inflammatory disease is suspected empiric treatment should be initiated.如果怀疑患有盆腔炎,应开始经验性治疗。
J Am Acad Nurse Pract. 2010 Feb;22(2):117-22. doi: 10.1111/j.1745-7599.2009.00478.x.
8
Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.育龄妇女因衣原体感染未得到治疗及相关盆腔炎导致的生产力损失。
Sex Transm Dis. 2006 Oct;33(10 Suppl):S117-21. doi: 10.1097/01.olq.0000235148.64274.2f.
9
Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.工业化国家急性盆腔炎及其后果的发病率、患病率和趋势。
Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):880-92. doi: 10.1016/0002-9378(80)91077-7.
10
Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?当前经济评估中使用的衣原体后遗症成本估算:一刀切是否可行?
Sex Transm Infect. 2017 Feb;93(1):18-24. doi: 10.1136/sextrans-2016-052597. Epub 2016 Jun 9.

引用本文的文献

1
Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective.阿奇霉素与多西环素治疗女性沙眼衣原体感染的成本效益分析:加拿大视角
Can J Infect Dis. 1997 Jul;8(4):202-8. doi: 10.1155/1997/870203.
2
Pelvic inflammatory disease: a family practice perspective.盆腔炎:家庭医疗视角
Can Fam Physician. 1989 Jun;35:1309-14.
3
Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.
与确诊的生殖道衣原体感染相关的严重生殖道并发症的发生率:乌普萨拉女性队列研究
Sex Transm Infect. 2006 Jun;82(3):212-8. doi: 10.1136/sti.2005.017186.
4
Lower Genital Tract Infections and HIV in Women.女性下生殖道感染与艾滋病病毒
Curr Infect Dis Rep. 2000 Dec;2(6):539-545. doi: 10.1007/s11908-000-0058-0.
5
Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.阿奇霉素。关于其单剂量方案用于治疗女性非复杂性泌尿生殖道沙眼衣原体感染的药物经济学综述。
Pharmacoeconomics. 1997 Nov;12(5):596-611. doi: 10.2165/00019053-199712050-00010.
6
Does sexual coercion play a role in the high-risk sexual behavior of adolescent and young adult women?
J Behav Med. 1995 Dec;18(6):549-68. doi: 10.1007/BF01857895.
7
Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.定期健康检查,1996年更新版:2. 衣原体感染筛查。加拿大定期健康检查特别工作组。
CMAJ. 1996 Jun 1;154(11):1631-44.
8
Measuring adolescent sexual behaviors and related health outcomes.测量青少年性行为及相关健康结果。
Public Health Rep. 1993;108 Suppl 1(Suppl 1):31-6.
9
Drug therapies for sexually transmitted diseases. Clinical and economic considerations.性传播疾病的药物治疗。临床与经济考量
Drugs. 1995 Apr;49(4):496-515. doi: 10.2165/00003495-199549040-00002.
10
Pelvic inflammatory disease: current concepts and treatment guidelines.盆腔炎性疾病:当前概念与治疗指南
J Gen Intern Med. 1986 Nov-Dec;1(6):412-7. doi: 10.1007/BF02596429.